Mr. Oussama El Othmani | Data Science and Deep Learning | Excellence in Research

Mr. Oussama El Othmani | Data Science and Deep Learning | Excellence in Research

Computer Engineering, Tunisia Polytechnic School, Tunisia

This individual is a promising researcher and software engineer with a strong background in computer science. Currently pursuing a PhD in ETIC at Tunisia Polytechnic School, University of Carthage La Marsa, they have a solid foundation in computer engineering from the Tunisian Military Academy. With experience as a software engineer at the Tunisian Ministry of National Defense, they have developed expertise in software development, collaboration, and problem-solving. Their research interests lie at the intersection of technology and innovation, with potential applications in various fields.

Profile

orcid

🎓 Education

– *PhD in ETIC*: Tunisia Polytechnic School, University of Carthage La Marsa, Tunis (2024 – Present)- *Computer Engineering*: Tunisian Military Academy, Fondik Jdid (2020-2023)- *Preparatory Mathematics-Physics*: Tunisian Military Academy, Fondik Jdid (2018-2020)- *Relevant Coursework*: Advanced Learning Algorithms, Artificial Intelligence, Computer Architecture, Database Management, Software Methodology, Project Management Fundamentals

👨‍🔬 Experience

– *Software Engineer*: Tunisian Ministry of National Defense (August 2023 – Present) – Participated in the full software development lifecycle – Collaborated with system engineers, hardware designers, and integration/test engineers – Developed optimized code for specific hardware platforms – Applied Agile development methodologies and object-oriented architectures

🔍 Research Interest

The individual’s research focus is not explicitly stated, but based on their education and experience, they may be interested in exploring topics related to artificial intelligence, computer architecture, and software methodology. Potential research areas could include machine learning, data science, and software engineering.

Awards and Honors🏆

No information is available on awards and honors received by the individual.

📚 Publications 

Rough Set Theory and Soft Computing Methods for Building Explainable and Interpretable AI/ML Models

Développement d’un système de détection des anomalies des cellules sanguines et son utilisation en télémédecine

BloodScan

Conclusion

The candidate shows promise for the Best Researcher Award with their relevant education, professional experience, and technical skills. However, additional research experience, interdisciplinary knowledge, and a stronger publication record would significantly enhance their application. With focused effort in these areas, the candidate could become a strong contender for the award.

alain R THIERRY | Data Science and Deep Learning | Excellence in Research

Prof. alain R THIERRY  | Data Science and Deep Learning | Excellence in Research

Director of Research, INSERM U1194, France

Dr. alain R THIERRY, a distinguished biologist, and cancer researcher, is a Director of Research at INSERM and a key figure at the Institut de Recherche en Cancérologie de Montpellier. With an impressive track record in molecular biology, gene therapy, and cancer research, Dr. alain R THIERRY has held numerous influential positions in academia and the biotechnology sector, including roles at NIH and Georgetown University. A prolific author and scientific leader, they have also founded biotech companies like MedinCell and DiaDx. Dr. alain R THIERRYcontinues to drive innovative therapeutic solutions, recognized by international honors and awards.

Publication Profile

Education🎓 

2003: Habilitation à Diriger les Recherches (HDR) in Biology-Health, Université Montpellier II 1987: CES in Human Biology (Oncology), Faculté de Médecine Paris-Sud 1986: PhD in Biochemistry, Cellular & Molecular Pharmacology, Université Montpellier II 1983: MSc in Cellular & Molecular Biology, Université de Clermont-Ferrand II 1983: Diplôme d’Ingénieur, Université Clermont-Fd II 1982: BSc in Biological Sciences & Technology, Université Clermont-Fd

Professional Experience💼 

208-present: Director of Research, INSERM, Institut de Recherche en Cancérologie, Montpellier 2001-2007: Associate Professor, Université Montpellier II2003-2004: Director of R&D, MedinCell SA, Montpellier 1997-2000: Scientific Director, Gene Therapy Dept., Biovector Therapeutics 1992-1996: Scientist, Tumor Cell Biology Lab, NCI/NIH, Bethesda 1992-1994: Adjunct Assistant Professor, Lombardi Cancer Institute, Washington DC 1988-1992: Postdoctoral Fellow, Lombardi Cancer Center, Georgetown University

Awards and Honors🏆 

1994: Federal Technology Award, NIH, USA ($10,000) 2002: Prix National de l’Innovation, Ministry of Education and Research, Paris (€300,000) 2016: Grand Prix de l’Innovation Thérapeutique, Fondation B. Denys & FRM, Montpellier (€50,000) 2022: Finalist, Prix Innovation Unicancer 2022: Innovation Award, Montpellier Université Excellence

Research Focus 🔬 

Molecular Oncology: Pioneer in understanding the molecular pathways of cancer and therapeutic gene delivery Gene Therapy: Focus on targeted gene therapy to treat cancers, with expertise in vectors and delivery systems Circulating DNA: Breakthrough research in non-invasive biomarkers for early cancer detection
Therapeutics Innovation: Key developer of novel therapeutic strategies, including drug delivery systems and cancer diagnostics
Collaborative Research: Strong interdisciplinary collaborations in biotechnology and cancer research

Publication  Top Notes

  • Origins, structures, and functions of circulating DNA in oncology
    AR Thierry, S El Messaoudi, PB Gahan, P Anker, M Stroun
    Cancer and Metastasis Reviews, 2016 | 812 citations
  • Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
    AR Thierry, F Mouliere, S El Messaoudi, C Mollevi, E Lopez-Crapez
    Nature Medicine, 2014 | 735 citations
  • Nomenclature for synthetic gene delivery systems
    PL Felgner, Y Barenholz, JP Behr, SH Cheng, P Cullis, L Huang, AR Thierry
    Human Gene Therapy, 1997 | 652 citations
  • High fragmentation characterizes tumour-derived circulating DNA
    F Mouliere, B Robert, E Arnau Peyrotte, M Del Rio, M Ychou, F Molina, AR Thierry
    PLOS One, 2011 | 627 citations
  • Circulating cell-free DNA: preanalytical considerations
    S El Messaoudi, F Rolet, F Mouliere, AR Thierry
    Clinica Chimica Acta, 2013 | 602 citations

Conclusion:

This individual is highly suitable for the Best Researcher Award. Their long-standing career in oncology research, leadership in both academic and biotech sectors, and recognition through awards place them in an elite category of researchers. Continued engagement in broader interdisciplinary fields and public communication could further elevate their profile. Overall, their qualifications, contributions, and leadership make them a strong candidate for excellence in research awards.